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Background: Hypertension is common and often left undiagnosed in the elderly. The main purpose of this
study was to evaluate the clinical characteristics of nondiabetic hypertensive older adults.
Methods: Community-living older adults in Taipei City participating in annual health examinations were
invited for study. Subjects with diabetes mellitus, whether treated or newly diagnosed, were excluded for
further analysis. All participants were classiﬁed into three groups: normotension, untreated hypertension
(UH), and treated hypertension (TH).
Results: In total, 3244 subjects (mean age: 73.4 5.4 years, 56.2% males) were enrolled. The prevalence of
hypertension, chronic kidney disease (CKD), and left ventricular hypertrophy (LVH) was 52.9% (36.1% TH
and 16.8% UH), 20.9%, and 6.2%, respectively. Compared with the normotension group, UH subjects were
older (73.8 5.5 years vs. 72.9 5.6 years, p¼ 0.003); having higher body mass index (24.2 3.4 kg/m2
vs. 23.6 3.4 kg/m2, p¼ 0.001), fasting glucose (101.7 9.1 mg/dL vs. 100.5 9.0 mg/dL, p¼ 0.007),
total cholesterol (TC) (205.0 37.8 mg/dL vs. 196.5 36.4 mg/dL, p< 0.001), triglyceride (TG)
(134.5 84.9 mg/dL vs. 119.4 77.0 mg/dL, p< 0.001); and higher prevalence of overt proteinuria (19.3%
vs. 13.5%, p¼ 0.001), CKD (21.1% vs. 16.6%, p¼ 0.025), and LVH (8.1% vs. 3.8%, p< 0.001). However, the
prevalence of overt proteinuria (19.3% vs. 21.1%, p¼ 0.378) and LVH (8.1% vs. 8.5%, p¼ 0.79) between UH
and TH groups was similar. Adjusted for age, TC, TG, fasting plasma glucose, and the incidence of LVH,
both UH [odds ratio (OR)¼ 1.30, 95% conﬁdence interval (CI)¼ 1.01e1.66, p¼ 0.040] and TH (OR¼ 1.69,
95% CI¼ 1.39e2.05, p< 0.001) were signiﬁcant risk factor for CKD. In addition, independent risk factors
for CKD included age (OR¼ 1.07, 95% CI¼ 1.05e1.09, p< 0.001), body mass index (OR¼ 1.07, 95%
CI¼ 1.04e1.10, p< 0.001), TC (OR¼ 1.003, 95% CI¼ 1.001e1.005, p¼ 0.021), TG (OR¼ 1.002, 95%
CI¼ 1.001e1.003, p< 0.001), and hypertension (TH or UH) (OR¼ 1.44, 95% CI¼ 1.20e1.72, p< 0.001).
Conclusion: In conclusion, risk of CKD existing along with blood pressure rises among nondiabetic older
hypertensive adults, and hypertension (TH or UH) carries a signiﬁcant risk of CKD after adjustment of
other cardiovascular risk factors. Renal protection should be highlighted in the antihypertensive treat-
ment strategy in older hypertensive patients.
Copyright  2011, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
Hypertension is a highly prevalent condition in older adults that
over three-quarters of people aged 70 and older are hypertensive,1
and the lifetime risk for hypertension exceeds 80% in both men andt to disclosure.
Gerontology, Taipei Veterans
ei 112, Taiwan.
n).
linical Gerontology & Geriatrics. Pwomen.2 Although progressive elevation of blood pressure is
a common feature of aging, it should not be considered as normal
aging because hypertension carries a continuous, consistent
cardiovascular risk that is independent of other risk factors.3 In
Taiwan, the prevalence of hypertension in older adults ranged
from 37.0% to 60.4%,4,5 and nearly 30% of hypertensive elderly
were undiagnosed (men 29.7%, women 28.8%).5 The success of
promoting awareness and treatment of hypertension has reduced
the incidence of stroke and cardiovascular disease,6 but the high
and progressively rising trend of end-stage renal disease (ESRD) inublished by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license.
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of ESRD in hypertensive patients may be partly explained by the
coexistence of hypertension and diabetes mellitus (DM),7 but aging
alone may play certain roles in this phenomenon.8
Glomerular ﬁltration rate (GFR) usually declines by 1e2 mL/
min/1.73 m2/yr in normotensive persons by the sixth decade of life,
but it can deteriorate to 4e8 mL/min/1.73 m2/yr if systolic blood
pressure is not well controlled.9 Altogether, aging and its associated
systolic blood pressure elevation may simultaneously increase the
cardiovascular risk and accelerate the GFR decline in older people.10
Although the importance of screening and treating hypertension
has been widely addressed, a certain percentage of people are still
unaware of their hypertensive status and may pose a particular risk
for cardiovascular disease. Beneﬁt of treating hypertension is well
known, but little is known about the risk of nephropathy in older
people with untreated hypertension. Presumably, the cardiovas-
cular risk of untreated hypertension may be an intermediate state
of normotension and treated hypertension. The main purpose of
this study was to compare clinical characteristics of nondiabetic
community-living elderly with untreated and treated hypertension
and to evaluate the risk factors for nephropathy of hypertensive
older adults in Taiwan.
2. Methods
2.1. Study subjects
In 2002, we retrospectively collected data from older adults
participating in the annual health examination (age older than
65 years) in Taipei City Hospital, Yangming Branch.11 All partici-
pants were enrolled when they agreed to participate. All partici-
pants received a comprehensive physical examination and their
blood was drawn for biochemical analysis after a 10-hour overnight
fast like our previous studies.12,13
2.2. Measurements
Blood pressure was measured bymercury sphygmomanometers
with auscultatory method, and hypertension was deﬁned by the
Seven Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure.6
Hypertensive status was categorized into: (1) normotension (NT),
(2) untreated hypertension (UH), and (3) treated hypertension (TH).
Body mass index (BMI) was expressed as body weight (in kilo-
grams) divided by the square of body length (in meters). Obesity
was deﬁned by Asia-Paciﬁc Obesity Recommendation as BMI of
25 kg/m2 or more, and overweight was deﬁned as BMI of 23 kg/m2
or more but less than 25 kg/m2.14
2.3. Laboratory tests
Biochemical tests, including serum levels of glucose, creatinine,
blood urea nitrogen, total cholesterol (TC), triglyceride (TG), and uric
acid,weredonebytheautomaticanalyzer (HitachiModel736,Tokyo,
Japan). DMwas diagnosed according to the diagnostic criteria of the
American Diabetes Association,15 and subjects with conﬁrmed DM,
with orwithout treatment,were subsequentlyexcluded fromfurther
analysis to avoid confounding effect of analysis on renal dysfunction.
Urine protein was tested by dipstick method, and trace proteinuria
was considered negative. GFR is estimated by the abbreviated
equation developed by the modiﬁed Modiﬁcation of Diet in Renal
Disease study forChinesepopulation:EstimatedGFR¼ 175 (serum
creatinine concentration)1.234 age0.179 (0.79 if female).16
Chronic kidney disease (CKD) was deﬁned according to the classiﬁ-
cation of the Kidney Disease Outcomes Quality Initiative of theNational Kidney Foundation. Stage III and IVCKDdenotes a decline in
GFR to 30e59 mL/min/1.73 m2 and 15e29 mL/min/1.73 m2, and
Stage V chronic kindney disease (ESRD)was deﬁned as GFR less than
15 mL/min/1.73 m2.17 Subjectswith Stage VCKDwere excluded from
the study. All electrocardiograms of study subjects were read by the
same cardiologist and carefully recorded.
2.4. Statistical analysis
Data in the text and tables are expressed as mean standard
deviation (mean SD). Results were compared between groups
depending on the type of data analyzed using the c2 test or
Student’s t test by using commercial statistical software (SPSS 17.0;
SPSS Inc, Chicago, IL, USA). Comparisons between hypertensive
groups were done by one-way analysis of variance. Multiple logistic
regression was used to determine independent risk factors for CKD
between subjects with UH and TH. For all tests, results with p values
less than 0.05 (two tailed) were considered statistically signiﬁcant.
3. Results
3.1. Demography
A total of 4116 subjects completed the health examinations.
Overall, 3244 subjects (mean age: 73.4 5.4 years, 56.1% males)
were enrolled after excluding 846 diabetic subjects and 26 subjects
with kidney failure. The overall prevalence of hypertension was
52.9%, which included 36.1% of TH and 16.8% of UH.
The mean BMI of all study subjects was 24.2 3.5 kg/m2, and
the percentage of obesity and overweight was 37.6% and 24.6%,
respectively. Mean serum levels of glucose, TC, TG, creatinine,
and uric acid were 101.5 9.1 mg/dL, 199.141.0 mg/dL,
129.2 87.9 mg/dL, 1.0 0.4 mg/dL, and 6.31.6 mg/dL, respec-
tively. The prevalence of overt proteinuria was 17.2%. The mean GFR
was 73.418.5 mL/min/1.73 m2, and 20.9% were classiﬁed as CKD.
Moreover, the prevalence of left ventricular hypertrophy (LVH) on
electrocardiograms was 6.2%.
3.2. Comparisons between NT and UH
The mean blood pressure of the NT group was 117.914.3/
68.710.4 mmHg and was 149.514.2/82.916.6 mmHg in the
UH group. Comparedwith the NTgroup, UH groupwas signiﬁcantly
older (73.8 5.5 years vs. 72.9 5.6 years, p¼ 0.003); having
higher BMI (24.2 3.4 kg/m2 vs. 23.6 3.4 kg/m2, p¼ 0.001);
higher fasting glucose (101.7 9.1 mg/dL vs. 100.5 9.0 mg/dL,
p¼ 0.007); higher serum TC (205.0 37.8 mg/dL vs.
196.5 36.4 mg/dL, p< 0.001); TGs (134.5 84.9 mg/dL vs.
119.477.0 mg/dL, p< 0.001); and higher prevalence of overt
proteinuria (19.3% vs. 13.5%, p¼ 0.001), CKD (21.1% vs. 16.6%,
p¼ 0.025), and LVH (8.1% vs. 3.8%, p< 0.001). However, mean GFR
(73.9 20.8 mL/min/1.73 m2 vs. 75.216.9 mL/min/1.73 m2,
p¼ 0.192), serum levels of creatinine (1.00 0.40 mg/dL vs.
0.99 0.36 mg/dL, p¼ 0.413), and uric acid (6.311.61 mg/dL vs.
6.221.56 mg/dL, p¼ 0.281) were statistically indistinguishable.
3.3. Comparisons between UH and TH
The mean blood pressure of UH group was 149.514.2/
82.916.6 mmHg and was 135.4 20.0/75.913.0 mmHg in the
TH group. Compared with the UH group, TH group had a signiﬁ-
cantly higher mean BMI (24.9 3.5 kg/m2 vs. 24.2 3.4 kg/m2,
p< 0.001), higher fasting glucose (102.7 9.1 mg/dL vs.
101.7 9.1 mg/dL, p¼ 0.031), lower TC (199.8 47.1 mg/dL vs.
205.0 37.8 mg/dL, p¼ 0.014), higher creatinine (1.06 0.43 mg/dL
Table 1
Comparisons of older people with different hypertensive status
Item Normotension
(n¼ 1529)
Untreated hypertension
(n¼ 544)
Treated hypertension
(n¼ 1171)
Total
(n¼ 3244)
p
Age (yr) 72.9 5.6 73.8 5.5 73.8 5.7 73.4 5.6 <0.001
Body mass index (kg/m2) 23.6 3.4 24.2 3.4 24.9 3.5 24.2 3.5 <0.001
Systolic pressure (mmHg) 117.9 14.3 149.5 14.2 135.4 20.0 129.5 20.4 <0.001
Diastolic pressure (mmHg) 68.7 10.4 82.9 16.6 75.9 13.0 73.7 19.1 <0.001
Glomerular ﬁltration rate
(mL/min/1.73 m2)
75.2 16.9 73.9 20.8 70.6 19.0 73.4 18.5 <0.001
Fasting glucose (mg/dL) 100.5 9.0 101.7 9.1 102.7 9.1 101.5 9.1 <0.001
Total cholesterol (mg/dL) 196.5 36.4 205.0 37.8 199.8 47.1 199.1 40.9 <0.001
Triglyceride (mg/dL) 119.4 77.0 134.5 84.9 139.6 100.3 129.2 87.9 <0.001
Creatinine (mg/dL) 0.99 0.36 1.00 0.40 1.06 0.43 1.02 0.40 <0.001
Uric acid (mg/dL) 6.2 1.6 6.3 1.6 6.5 1.6 6.3 1.6 <0.001
Proteinuria (%) 13.5 19.3 21.1 17.2 <0.001
Chronic kidney disease (%) 16.6 21.1 26.4 20.9 <0.001
Left ventricular hypertrophy (%) 3.8 8.1 8.5 6.2 <0.001
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1.62 mg/dL vs. 6.311.61 mg/dL, p¼ 0.017), lower mean GFR
(70.619.0 mL/min/1.73 m2 vs. 73.9 20.8 mL/min/1.73 m2, p¼
0.002), and higher prevalence of CKD (26.4% vs. 21.1%, p¼ 0.018). On
the other hand, differences in age (73.8 5.7 years vs. 73.8 5.5
years, p¼ 0.760), serum levels of TG (139.6100.3 mg/dL vs.
134.5 84.9 mg/dL, p¼ 0.278), prevalence of overt proteinuria
(21.1% vs. 19.3%, p¼ 0.378), and LVH (8.5% vs. 8.1%, p¼ 0.79) did not
reach statistical signiﬁcance. Comparisons of subjects with
different hypertensive status by using one-way analysis of variance
test showed signiﬁcant differences in all aforementioned variables,
and the trend of progression was evident in all variables except
serum TC (Table 1).
3.4. Risk factors for CKD
Adjusted for age, TC, TG, fasting plasma glucose, and the inci-
dence of LVH, both UH [odds ratio (OR)¼ 1.30, 95% conﬁdence
interval (CI)¼ 1.01e1.66, p¼ 0.040] and TH (OR¼ 1.69, 95%
CI¼ 1.39e2.05, p< 0.001) were signiﬁcant risk factor for CKD
(Table 2). In addition, independent risk factors for CKD included age
(OR¼ 1.07, 95% CI¼ 1.05e1.09, p< 0.001), BMI (OR¼ 1.07, 95%
CI¼ 1.04e1.10, p< 0.001), TC (OR¼ 1.003, 95% CI¼ 1.001e1.005,
p¼ 0.021), TG (OR¼ 1.002, 95% CI¼ 1.001e1.003, p< 0.001), and
hypertension (TH or UH) (OR¼ 1.44, 95% CI¼ 1.20e1.72, p< 0.001).
4. Discussion
Elevation of blood pressure is a common characteristic of aging,
and the associated cardiovascular risk is constant and continuous as
blood pressure rises. Previous reports indicated that more than
one-half of older adults are hypertensive, no matter in Western
countries or in Taiwan.2,5 However, a certain proportion of elderly
people was unaware of hypertension because of various reasons,
which was 29.3% in southern Taiwan5 and 16.8% in this study.
Although awareness and treatment rate of hypertension have beenTable 2
Independent risk factor for chronic kidney disease among older adults in Taiwan
Item Odds
ratio
95% Conﬁdence
interval
p
Age 1.06 1.05e1.08 <0.001
Total cholesterol 1.003 1.001e1.005 0.23
Triglyceride 1.003 1.002e1.004 <0.001
Untreated hypertension vs.
normotension
1.30 1.01e1.66 0.40
Treated hypertension vs.
normotension
1.69 1.39e2.05 <0.001signiﬁcantly improved in recent years, undiagnosed and untreated
hypertension is still a hidden public health issue. Most previous
emphasis on hypertension screening is focused on the impact of
cardiovascular disease and heart failure. This study clearly showed
that most clinical characteristics of UH is an intermediate state
between NT and TH, but the high prevalence of LVH and CKD
deserve particular attentions because they are predictors of heart
failure and ESRD.
Improved hypertension awareness, treatment, and control are
associated with marked declines in stroke- and coronary heart
disease-related mortality. However, the uprising trend of heart
failure and ESRD in along with the success of hypertension treat-
ment has become another challenge in hypertension manage-
ment.6 A previous report has indicated that mild renal dysfunction
(deﬁned by microalbuminuria or a GFR level less than 60 mL/min)
is present in 12.5% of UH subjects,18 and it is associated with
a higher incidence of cardiovascular events and a greater decline of
GFR in the future.19 In this study, the mean GFR was signiﬁcantly
lower in UH group and the prevalence of CKD reached 21.1%, which
was signiﬁcantly higher than NT and that was reported in Cauca-
sians.18 Although some adverse outcomes of CKD can be prevented
or delayed by early detection and early intervention, early diagnosis
and treatment of CKD are still inadequate.20e23 Despite GFR decline
is part of normal aging process, CKD still independently predicts
adverse outcomes in older people, for example, cardiovascular
disease and death.24e26 The prevalence of CKD was approximately
17% among people aged older than 60 years,27 but it reached 20.9%
in this cohort (aged older than 65 years). Moreover, the mean GFR
and prevalence of CKD were aggravated as blood pressure status
progressed. In addition, subjects with TH were signiﬁcantly older,
having higher BMI, higher serum levels of fasting glucose, TGs,
creatinine, and uric acid. However, the lower serum TC among TH
group may be caused by the use of lipid-lowering agents because
they may have been clinically treated for all cardiovascular risk
factors. Nevertheless, a complete medication record was not
available in the study.
Notably, the prevalence of LVH was signiﬁcantly higher in UH
group than the NT group and was similar to that in the TH group.
Theoretically, LVH regression may be achieved if hypertension is
well controlled, irrespective of drug of choice.28 This study clearly
showed that older people with untreated hypertension were more
likely to have LVH, as much as treated hypertension, and the
progression may be delayed when hypertension is treated. More-
over, the higher BMI, fasting glucose, and serum TG of the TH group
imply the possibilities of metabolic syndrome, which deserves
further investigations and clinical intervention. Multiple logistic
regression analysis showed that both UH and TH were signiﬁcant
risk factor for CKD after adjustment of other cardiovascular risk
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consider to be treated because of existing cardiovascular disease
and increased predicted risk of cardiovascular disease, especially
among the elderly. It represents that TH patients may have more
cardiovascular risks than UH, which may explain the risk of CKD in
TH is higher than UH in our study.29 In addition, hypertension alone
(TH or UH) carries signiﬁcant independent risk for CKD after
adjustment of other cardiovascular risk factors. Therefore, renal
protection should be highlighted when antihypertensive treatment
is considered in older adults. This implies that no matter which
class of antihypertensive agent was selected for older hypertensive
patients, clinicians should pay more attentions to its renal protec-
tion beyond blood pressure lowering.
There are several limitations in this study. First, participants
were not systematically sampled from the general population,
which may limit the abilities for extrapolation. The wills of subjects
participating in the physical examinations may represent certain
characteristics in the general population, which is supported by
a low undiagnosed hypertension rate in this study. On the contrary,
we believe the risk of untreated hypertension for older people in
the communities in developing heart failure and ESRD is under-
estimated, and more attentions should be paid to enhance hyper-
tension screening in the communities. Second, the cross-sectional
observational design of this study also limits the evaluation of
causal relationship in this study. Further investigation is needed to
evaluate the long-term outcomes of antihypertensive treatment
among these UH subjects. Third, the proﬁle of comorbid cardio-
vascular risk factors was not comprehensively evaluated. However,
we believe this study still clearly pictured the clinical characteris-
tics of nondiabetic elderly with different hypertensive status and
provide certain important information in estimating the potential
health hazards of undiagnosed hypertension in the elderly pop-
ulation. Moreover, this study showed that the GFR decline and LVH
were present earlier than the diagnosis of hypertension was made.
Although the prevalence of undiagnosed hypertension in this study
is lower than a previous study in Taiwan, results from this study
clearly supported a more aggressive hypertension-screening
program.
In conclusion, the overall prevalence of hypertension among
nondiabetic older adults in Taipei was 52.9%, and 16.8% of them
were undiagnosed before study. Renal dysfunction and LVH were
already present before the diagnosis of hypertension was made.
Renal protection should be highlighted in the antihypertensive
treatment strategy in older hypertensive patients, even in nondi-
abetic older patients.
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